• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Definium Therapeutics, Inc. - Common Shares (NQ:DFTX)

18.45 -0.60 (-3.15%)
Streaming Delayed Price Updated: 11:59 AM EDT, Mar 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 491,857
Open 18.95
Bid (Size) 18.44 (1,100)
Ask (Size) 18.46 (200)
Prev. Close 19.05
Today's Range 18.45 - 19.02
52wk Range 14.62 - 19.62
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Definium Therapeutics Announces New Employee Inducement Grants
March 09, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium (DFTX) Q4 2025 Earnings Call Transcript ↗
February 27, 2026
Definium (DFTX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings

Performance

YTD
+20.0%
+20.0%
1 Month
+6.3%
+6.3%
3 Month
+20.0%
+20.0%
6 Month
+20.0%
+20.0%
1 Year
+20.0%
+20.0%

More News

Read More
News headline image
Definium Therapeutics Reports Full-Year 2025 Financial Results and Business Updates
February 26, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics to Participate at Upcoming Investor Conferences
February 24, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026
February 19, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics Announces New Employee Inducement Grants
February 02, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics Appoints Roger Adsett to Board of Directors
January 29, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics Announces New Employee Inducement Grants
January 26, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care
January 20, 2026
From Definium Therapeutics, Inc.
Via Business Wire
News headline image
2026 Asset Growth: Why Federal Compliance Is the New Metric
January 19, 2026
From Equity Insider
Via GlobeNewswire

Frequently Asked Questions

Is Definium Therapeutics, Inc. - Common Shares publicly traded?
Yes, Definium Therapeutics, Inc. - Common Shares is publicly traded.
What exchange does Definium Therapeutics, Inc. - Common Shares trade on?
Definium Therapeutics, Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Definium Therapeutics, Inc. - Common Shares?
The ticker symbol for Definium Therapeutics, Inc. - Common Shares is DFTX on the Nasdaq Stock Market
What is the current price of Definium Therapeutics, Inc. - Common Shares?
The current price of Definium Therapeutics, Inc. - Common Shares is 18.45
When was Definium Therapeutics, Inc. - Common Shares last traded?
The last trade of Definium Therapeutics, Inc. - Common Shares was at 03/11/26 11:59 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap